All Posts

Mounjaro (tirzepatide) and Wegovy (semaglutide) are among the most effective weight loss medications available in the UK. For the majority of patients, the benefits of significant, sustained weight loss and improved metabolic health far outweigh the side effects. However, side effects are real, and managing them well is essential for staying on treatment long enough to achieve your goals. This guide, written from a GP teams clinical perspective, explains the most common side

One of the most underappreciated risks of GLP-1 medication, including Mounjaro (tirzepatide) and Wegovy (semaglutide), is the potential for muscle loss alongside fat loss. Without the right support, a significant proportion of the weight you lose may come from lean muscle mass rather than body fat, which has serious long-term consequences for your metabolism, strength, and overall health. The good news is that muscle loss during GLP-1 therapy is not inevitable. With the right

Calleva Clinic offers safe, medically supervised weight loss injections with personalised care

Learn how being overweight increases your risk of cancers. https://www.cancerresearchuk.org/about-cancer/causes-of-cancer/obesity-weight-and-cancer/how-does-obesity-cause-cancer. We can support you on your weight loss journey.

It’s important to understand that obesity is not a choice, and each person’s journey to lose weight is unique. For some, especially those who have lost some weight, putting in more effort into a weight-loss program may not always lead to additional weight reduction due to the body’s adaptive mechanisms to resist weight loss' (uk.lilly.com/metabolic/public/obesity)